Sandra Patterson - 01 Mar 2023 Form 3 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controllership
Signature
/s/ Amy Kim by Power of Attorney for Sandra C. Patterson
Issuer symbol
GILD
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
3
Filing time
09 Mar 2023, 19:27:45 UTC
Next filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GILD Common Stock 24,092 01 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GILD Non-qualified Stock Option (Right to Buy) 01 Mar 2023 Common Stock 10,660 $57.92 Direct F1
holding GILD Restricted Stock Unit 01 Mar 2023 Common Stock 6,629 Direct F2, F3
holding GILD Restricted Stock Unit 01 Mar 2023 Common Stock 10,371 Direct F3, F4
holding GILD Restricted Stock Unit 01 Mar 2023 Common Stock 2,349 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F4 The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.
F5 The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.